ha 1004 has been researched along with n-(2-aminoethyl)-5-isoquinolinesulfonamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerena, L; Geyer, JA; Keenan, SM; Waters, NC; Welsh, WJ; Woodard, CL | 1 |
| Mašič, LP; Škedelj, V; Tomašić, T; Zega, A | 1 |
| Ito, M; Sato, A; Shigeta, S; Takami, Y; Tanabe, F | 1 |
1 review(s) available for ha 1004 and n-(2-aminoethyl)-5-isoquinolinesulfonamide
| Article | Year |
|---|---|
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Drug Design; Humans; Models, Molecular; Molecular Targeted Therapy | 2011 |
2 other study(ies) available for ha 1004 and n-(2-aminoethyl)-5-isoquinolinesulfonamide
| Article | Year |
|---|---|
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inhibitory Concentration 50; Ligands; Malaria; Molecular Conformation; Naphthalenes; Plasmodium falciparum; Sulfonamides | 2007 |
A potent inhibitor of protein kinase C inhibits natural killer activity.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Cell Line, Transformed; Humans; Isoquinolines; Killer Cells, Natural; Piperazines; Protein Kinase C; Sulfonamides | 1988 |